ZFAS1 and myocardial infarction: The reversible nature of the effect of ZFAS1 was observed following the knockdown, suggesting that targeting ZFAS1 with anti-ZFAS1 agents could serve as a novel therapeutic approach to safeguard cardiomyocytes from apoptosis generated by myocardial infarction [57,58].